(FDMT) 4D Molecular - Performance -87.7% in 12m
Compare FDMT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-82.39%
#144 in Group
Rel. Strength
2.04%
#7795 in Universe
Total Return 12m
-87.69%
#183 in Group
Total Return 5y
-92.00%
#119 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -61.20%
(?) Percentile in Group
12m Total Return: FDMT (-87.7%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: FDMT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FDMT
Total Return (including Dividends) | FDMT | XBI | S&P 500 |
---|---|---|---|
1 Month | 29.08% | 11.81% | 13.81% |
3 Months | -39.04% | -13.61% | -6.30% |
12 Months | -87.69% | -12.29% | 10.65% |
5 Years | -92.00% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | FDMT | XBI | S&P 500 |
1 Month | 66.0% | 72.9% | 83% |
3 Months | -83.7% | -83% | -75.3% |
12 Months | -98.5% | -51.6% | 50.1% |
5 Years | -56.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #63 | 15.5% | 13.4% |
3 Month | #163 | -29.4% | -34.9% |
12 Month | #184 | -86.0% | -88.9% |
5 Years | #106 | -85.5% | -95.1% |
FAQs
Does FDMT 4D Molecular outperforms the market?
No,
over the last 12 months FDMT made -87.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months FDMT made -39.04%, while XBI made -13.61%.
Over the last 3 months FDMT made -39.04%, while XBI made -13.61%.
Performance Comparison FDMT vs Indeces and Sectors
FDMT vs. Indices FDMT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.99% | 15.3% | -55.2% | -98.3% |
US NASDAQ 100 | QQQ | -7.18% | 11.7% | -55.4% | -99.3% |
US Dow Jones Industrial 30 | DIA | -7.40% | 19.1% | -54.9% | -95.4% |
German DAX 40 | DAX | -6.97% | 14.1% | -81.4% | -113% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.17% | 17.3% | -55.9% | -95.1% |
Hongkong Hang Seng | HSI | -10.2% | 9.15% | -63.5% | -101% |
India NIFTY 50 | INDA | -2.07% | 24.2% | -55.6% | -87.5% |
Brasil Bovespa | EWZ | -8.04% | 11.8% | -63.9% | -79.4% |
FDMT vs. Sectors FDMT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -7.63% | 15.7% | -62.2% | -109% |
Consumer Discretionary | XLY | -7.37% | 14.9% | -54.2% | -102% |
Consumer Staples | XLP | -6.13% | 22.5% | -62.1% | -96.8% |
Energy | XLE | -6.81% | 22.3% | -48.6% | -78.2% |
Financial | XLF | -8.09% | 15.6% | -62.3% | -110% |
Health Care | XLV | -3.98% | 28.2% | -50.2% | -83.6% |
Industrial | XLI | -8.68% | 12.3% | -56.6% | -98.7% |
Materials | XLB | -6.79% | 15.5% | -50.3% | -82.5% |
Real Estate | XLRE | -5.67% | 17.5% | -55.9% | -103% |
Technology | XLK | -8.07% | 7.86% | -52.3% | -94.8% |
Utilities | XLU | -7.04% | 19.5% | -62.8% | -105% |
Aerospace & Defense | XAR | -8.97% | 7.92% | -66.7% | -115% |
Biotech | XBI | -0.40% | 17.3% | -35.0% | -75.4% |
Homebuilder | XHB | -7.46% | 17.6% | -42.0% | -80.1% |
Retail | XRT | -8.89% | 14.4% | -50.9% | -86.2% |